Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

A treatment called CAR T-cell therapy, which precisely targets cancerous tumors using genetic modification techniques, is fast becoming a popular and highly effective treatment for certain forms of ...

GenScript ensures that suppliers adhere to PSCI's core principles regarding environment, ethics, human rights, health and safety, and management systems. By incorporating PSCI requirements into its ...

After years of losses, Legend Biotech’s new cancer drug Cavykti offers it a chance to finally start contributing revenue to its parent, Genscript Biotech. Some analysts believe Genscript may have ...